Skip to content
Preprint via OpenAlex

Telomeres and metabolism : Part 1. Functional interplay between the telomere maintenance and mTOR pathways. Part 2. RAP1 role in chemically-induced hepatocellular carcinoma

Iole Ferrara Romeo

Dialnet (Universidad de la Rioja) · 2019

Abstract

Telomeres are specialized nucleoprotein structures at the end of linear chromosomes that protect them from degradation and repair activities. Dysfunctional telomeres activate a DNA damage response, which eventually results in cell growth arrest, senescence(definition) and/or apoptosis, leading to a reduction of the regenerative potential of the tissues. Telomeres shorten with each cell division throughout the organismal life and telomere(definition) shortening is defined as a primary cause of aging-associated diseases. The development of metabolic disorders, in turn, is also a phenotype of advancing age. Although some works have reported about the link between telomeres and metabolism, it still remains a fairly unexplored field to date. Telomeres are elongated by the telomerase, a specialized enzyme whose expression is very restricted in adulthood. Telomerase deficiency in mice and humans leads to short telomeres, premature appearance of age-related diseases, and a shorter lifespan. Inhibition of the nutrient sensing pathway regulated by the mechanistic target of mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition) (mTOR) increases lifespan in numerous species from yeast to mice and is considered a major target to delay aging and age-related pathologies. In light of the beneficial effects of the mTOR pathway inhibition in extending longevity, we have addressed whether rapamycin treatment could ameliorate the premature aging phenotypes and the decreased longevity of telomerase-deficient mice with short telomeres. This is of potential relevance as mTOR inhibitors could represent new potential treatments for human patients suffering from “telomere syndromes”. To address the role of mTOR in the survival of telomerase-deficient mice with short telomeres (second generation, G2, Terc-/- mice), we treated them with rapamycin, an inhibitor of mTOR. We found that chronic rapamycin treatment decreased the survival of G2 Terc-/- mice, in marked contrast to significant lifespan extension in the case of similarly treated wild-type controls. Telomerase-deficient mice with short telomeres have a hyper-activated mTOR pathway. By using mouse genetics, we further confirm that abrogation of the mTOR downstream target S6 kinase 1 in S6K1-/-/Terc-/- double mutant mice also decreases mouse longevity compared to single Terc-/- controls, in contrast to lifespan extension in the case of single S6K1-/- female mice. Together, these findings demonstrate that the mTOR pathway is an essential survival pathway in the context of telomerase deficiency and the presence of short telomeres, and its inhibition in this setting is deleterious. The protein component of the telomere is a six-protein complex named shelterin. RAP1 is a component of shelterin known to have both telomeric and non-telomeric functions and is involved in the regulation of metabolic programs. RAP1-deficient mice develop obesity and hepatic steatosis, being these phenotypes more severe in females than in males. As hepatic steatosis and obesity have been related to increased liver cancer in mice and humans, we set out to address whether RAP1 deficiency results in increased liver cancer upon chemical liver carcinogenesis. We found that Rap1-/- females were more susceptible to DEN-induced liver damage and hepatocellular carcinoma (HCC). DEN-treated Rap1-/- female livers showed an earlier onset of both premalignant and malignant lesions that metastasize more rapidly to the lungs. These findings highlight an important role for RAP1 in protection from liver damage and liver cancer.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
Canonical
link ↗
Fetched
2026-10-07 MST

Cite this

APA
Romeo, I.F. (2019). Telomeres and metabolism : Part 1. Functional interplay between the telomere maintenance and mTOR pathways. Part 2. RAP1 role in chemically-induced hepatocellular carcinoma. <em>Dialnet (Universidad de la Rioja)</em>. https://openalex.org/W2996894141
Vancouver
Romeo IF. Telomeres and metabolism : Part 1. Functional interplay between the telomere maintenance and mTOR pathways. Part 2. RAP1 role in chemically-induced hepatocellular carcinoma. Dialnet (Universidad de la Rioja). 2019.
BibTeX
@unpublished{iole2019Telome, title = {Telomeres and metabolism : Part 1. Functional interplay between the telomere maintenance and mTOR pathways. Part 2. RAP1 role in chemically-induced hepatocellular carcinoma}, author = {Iole Ferrara Romeo}, journal = {Dialnet (Universidad de la Rioja)}, year = {2019}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings